Tuberculosis-immune reconstitution inflammatory syndrome is an excessive immune response against Mycobacterium tuberculosis that may occur in either HIV-infected or uninfected patients, during or after completion of anti-TB therapy. In HIV-infected patients it occurs after initiation of antiretroviral therapy independently from an effective suppression of HIV viremia. There are two forms of IRIS: paradoxical or unmasking. Paradoxical IRIS is characterized by recurrent, new, or worsening symptoms of a treated case. Unmasking IRIS is an antiretroviral-associated inflammatory manifestation of a subclinical infection with a hastened presentation. The pathogenesis is incompletely understood and the epidemiology partially described. No specific tests can establish or rule out the diagnosis. Treatment is based on the use of anti-tuberculosis drugs sometime with adjunctive corticosteroids. Mortality is generally low.

Tuberculosis-immune reconstitution inflammatory syndrome / Lanzafame, M., Vento, S.. - In: JOURNAL OF CLINICAL TUBERCULOSIS AND OTHER MYCOBACTERIAL DISEASES. - ISSN 2405-5794. - 3:(2016), pp. 6-9. [10.1016/j.jctube.2016.03.002]

Tuberculosis-immune reconstitution inflammatory syndrome

Lanzafame, Massimiliano;
2016-01-01

Abstract

Tuberculosis-immune reconstitution inflammatory syndrome is an excessive immune response against Mycobacterium tuberculosis that may occur in either HIV-infected or uninfected patients, during or after completion of anti-TB therapy. In HIV-infected patients it occurs after initiation of antiretroviral therapy independently from an effective suppression of HIV viremia. There are two forms of IRIS: paradoxical or unmasking. Paradoxical IRIS is characterized by recurrent, new, or worsening symptoms of a treated case. Unmasking IRIS is an antiretroviral-associated inflammatory manifestation of a subclinical infection with a hastened presentation. The pathogenesis is incompletely understood and the epidemiology partially described. No specific tests can establish or rule out the diagnosis. Treatment is based on the use of anti-tuberculosis drugs sometime with adjunctive corticosteroids. Mortality is generally low.
2016
Lanzafame, Massimiliano; Vento, Sandro
Tuberculosis-immune reconstitution inflammatory syndrome / Lanzafame, M., Vento, S.. - In: JOURNAL OF CLINICAL TUBERCULOSIS AND OTHER MYCOBACTERIAL DISEASES. - ISSN 2405-5794. - 3:(2016), pp. 6-9. [10.1016/j.jctube.2016.03.002]
File in questo prodotto:
File Dimensione Formato  
Journal of clinical tuberculosis and other 2016.pdf

accesso aperto

Tipologia: Versione editoriale (Publisher’s layout)
Licenza: Creative commons
Dimensione 369.42 kB
Formato Adobe PDF
369.42 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11572/453031
Citazioni
  • ???jsp.display-item.citation.pmc??? 61
  • Scopus 90
  • ???jsp.display-item.citation.isi??? ND
  • OpenAlex 121
social impact